반응식
[CH3:1][O:2][C:3]1[C:4]([O:25][CH3:26])=[CH:5][C:6]2[C:7]3[N:8]([CH2:22][CH2:23][N:24]=3)[C:9](/[CH:13]=[C:14](/[C:16]3[CH:17]=[N:18][CH:19]=[CH:20][CH:21]=3)\[OH:15])=[N:10][C:11]=2[CH:12]=1.[ClH:27]>O1CCOCC1>[ClH:27].[CH3:1][O:2][C:3]1[C:4]([O:25][CH3:26])=[CH:5][C:6]2[C:7]3[N:8]([CH2:22][CH2:23][N:24]=3)[C:9](/[CH:13]=[C:14](/[C:16]3[CH:17]=[N:18][CH:19]=[CH:20][CH:21]=3)\[OH:15])=[N:10][C:11]=2[CH:12]=1참가 물질
4
실험 절차
To a solution of (Z-2-(8,9-dimethoxy-2,3-dihydroimidazo[1,2-c]quinazolin-5-yl)-1-(3-pyridinyl)ethenol (16.8 mg, 0.05 mmol)) in dioxane (15 ml) at room temperature was added aqueous 6N HCl solution (0.05 ml). After being stirred for 30 minutes, the mixture was dried under reduced pressure to give (Z)-2-(8,9-dimethoxy-2,3-di-hydroimidazo[1,2-c]quinazolin-5-yl)-1-(3-pyridinyl)ethenol hydrochloride (18.5 mg, quantitative) as a yellow solid.
후처리
- customthe mixture was dried under reduced pressure
출처 및 근거
- ORD 기록
- ord-66d5e11f577345e3a22171496eb71fe6
- 출처 데이터셋
- uspto-grants-2009_03
- 특허 번호
- US07511041B2
연결된 노트
불러오는 중…